Accueil/Actions/GDTC

GDTC

USD

CytoMed Therapeutics Limited Ordinary Shares

$1.990-0.070 (-3.398%)

Prix en Temps Réel

Healthcare

Biotechnologie

Singapour

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché

Fondamentaux de l'Entreprise

Statistiques de Trading

Métriques de Marché

Ouverture

$2.060

Haut

$2.060

Bas

$1.920

Volume

0.00M

Fondamentaux de l'Entreprise

Capitalisation Boursière

23.4M

Industrie

Biotechnologie

Pays

Singapore

Statistiques de Trading

Volume Moyen

0.07M

Bourse

NCM

Devise

USD

Intervalle sur 52 Semaines

Bas $1.65Actuel $1.990Haut $4.05

Actualités Connexes

28 août 2025 · 13:00

GlobeNewswire

Update on recent acquisition - CytoMed Therapeutics expands into auto-immune diseases building on its recent cord blood bank acquisition

SINGAPORE, Aug. 28, 2025 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ:GDTC) ("CytoMed" or "Company"), a Singapore-based clinical stage biopharmaceutical company focused on harnessing its proprietary

Update on recent acquisition - CytoMed Therapeutics expands into auto-immune diseases building on its recent cord blood bank acquisition

19 août 2025 · 01:00

GlobeNewswire

CytoMed Therapeutics Limited Announces At-the-Market (ATM) Offering Program

SINGAPORE, Aug. 18, 2025 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ:GDTC) ("CytoMed" or "Company"), a Singapore-based clinical stage biopharmaceutical company focused on harnessing its proprietary